[1]JournaloftheAmericanChemicalSociety,1959,vol.81,p.704,707
[1]BioorganicandMedicinalChemistry,2018,vol.26,#3,p.647-660
[2]Patent:US5962458,1999,A,
[3]Patent:US6362336,2002,B1,.Locationinpatent:Example63
[4]HelveticaChimicaActa,1955,vol.38,p.1046,1058
[5]BulletindelaSocieteChimiquedeFrance,1958,p.687,691
[6]JournaloftheAmericanChemicalSociety,1959,vol.81,p.704,707
[1]Patent:US5962458,1999,A,
[1]Patent:WO2012/153253,2012,A2,.Locationinpatent:Page/Pagecolumn67
[1]TetrahedronLetters,2007,vol.48,#6,p.999-1002
[2]BioorganicandMedicinalChemistryLetters,2012,vol.22,#14,p.4629-4635
[3]Chemistry-AEuropeanJournal,2015,vol.21,#33,p.11745-11756
[1]JournaloftheAmericanChemicalSociety,1959,vol.81,p.704,707
[1]JournaloftheAmericanChemicalSociety,1959,vol.81,p.704,707
[1]TakedaKenkyushoNenpo,1953,vol.12,p.62,64 Chem.Abstr.,1954,p.4695
[1]TetrahedronLetters,2007,vol.48,p.999-1002
[2]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.4629-4635
[3]Chemistry-AEuropeanJournal,2015,vol.21,p.11745-11756
[1]TetrahedronLetters,2007,vol.48,p.999-1002
[2]Tetrahedron,2009,vol.65,p.7673-7686
Title: Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization.
Journal: Journal of medicinal chemistry 20101111